- Home
- DLPN vs RDHL Comparison
DLPN vs RDHL Comparison
Compare DLPN & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLPN
- RDHL
- Stock Information
- Founded
- DLPN N/A
- RDHL 2009
- Country
- DLPN United States
- RDHL Israel
- Employees
- DLPN N/A
- RDHL N/A
- Industry
- DLPN Other Consumer Services
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- DLPN Consumer Discretionary
- RDHL Health Care
- Exchange
- DLPN Nasdaq
- RDHL Nasdaq
- Market Cap
- DLPN 15.8M
- RDHL 13.1M
- IPO Year
- DLPN N/A
- RDHL N/A
- Fundamental
- Price
- DLPN $0.66
- RDHL $8.16
- Analyst Decision
- DLPN
- RDHL
- Analyst Count
- DLPN 0
- RDHL 0
- Target Price
- DLPN N/A
- RDHL N/A
- AVG Volume (30 Days)
- DLPN 31.2K
- RDHL 37.3K
- Earning Date
- DLPN 11-12-2024
- RDHL 10-15-2024
- Dividend Yield
- DLPN N/A
- RDHL N/A
- EPS Growth
- DLPN N/A
- RDHL N/A
- EPS
- DLPN N/A
- RDHL N/A
- Revenue
- DLPN $48,891,700.00
- RDHL $3,707,000.00
- Revenue This Year
- DLPN $19.92
- RDHL $224.90
- Revenue Next Year
- DLPN $8.88
- RDHL $82.69
- P/E Ratio
- DLPN N/A
- RDHL N/A
- Revenue Growth
- DLPN 16.54
- RDHL N/A
- 52 Week Low
- DLPN $0.51
- RDHL $6.43
- 52 Week High
- DLPN $2.07
- RDHL $82.00
- Technical
- Relative Strength Index (RSI)
- DLPN 47.56
- RDHL 40.13
- Support Level
- DLPN $0.55
- RDHL $7.95
- Resistance Level
- DLPN $0.72
- RDHL $9.05
- Average True Range (ATR)
- DLPN 0.08
- RDHL 0.61
- MACD
- DLPN 0.00
- RDHL -0.20
- Stochastic Oscillator
- DLPN 62.92
- RDHL 6.73
About DLPN Dolphin Entertainment Inc.
Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.